Oncovista Innovative Therapies Stock Today
| OVIT Stock | USD 0.0001 0.00 0.00% |
Performance0 of 100
| Odds Of DistressLess than 9
|
OncoVista Innovative is selling for under 1.0E-4 as of the 2nd of December 2024; that is No Change since the beginning of the trading day. The stock's last reported lowest price was 1.0E-4. OncoVista Innovative has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for OncoVista Innovative Therapies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 3rd of September 2024 and ending today, the 2nd of December 2024. Click here to learn more.
OncoVista Innovative Therapies, Inc., a biopharmaceutical company, develops targeted anticancer therapies by utilizing tumor-associated biomarkers. The company was founded in 2004 and is based in San Antonio, Texas. ONCOVISTA INNOVATIVE operates under Biotechnology classification in the United States and is traded on OTC Exchange. The company has 23.56 M outstanding shares. More on OncoVista Innovative Therapies
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
OncoVista Pink Sheet Highlights
| Chairman | Alexander Weis |
| Business Concentration | Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
OncoVista Innovative Therapies [OVIT] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 558.34 K. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate OncoVista Innovative's market, we take the total number of its shares issued and multiply it by OncoVista Innovative's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. OncoVista Innovative conducts business under Biotechnology sector and is part of Health Care industry. The entity has 23.56 M outstanding shares.
OncoVista Innovative Therapies currently holds about 61.27 K in cash with (232.38 K) of positive cash flow from operations.
Check OncoVista Innovative Probability Of Bankruptcy
OncoVista Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in OncoVista Innovative without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stock Tickers Now
Stock TickersUse high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
| All Next | Launch Module |
Additional Tools for OncoVista Pink Sheet Analysis
When running OncoVista Innovative's price analysis, check to measure OncoVista Innovative's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy OncoVista Innovative is operating at the current time. Most of OncoVista Innovative's value examination focuses on studying past and present price action to predict the probability of OncoVista Innovative's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move OncoVista Innovative's price. Additionally, you may evaluate how the addition of OncoVista Innovative to your portfolios can decrease your overall portfolio volatility.